Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 28:13:31-32.
doi: 10.1016/j.ymgmr.2017.07.009. eCollection 2017 Dec.

Mitochondrial multiorgan disorder syndrome (MIMODS) due to a compound heterozygous mutation in the ACAD9 gene

Josef Finsterer  1 , Sinda Zarrouk-Mahjoub  2
Affiliations

Mitochondrial multiorgan disorder syndrome (MIMODS) due to a compound heterozygous mutation in the ACAD9 gene

Josef Finsterer et al. Mol Genet Metab Rep. .
No abstract available

Keywords: Abnormal immune response; Genotype; Lymphocytes; Mitochondrial; Phenotype; mtDNA.

PubMed Disclaimer

References

    1. Fragaki K., Chaussenot A., Boutron A., Bannwarth S., Rouzier C., Chabrol B., Paquis-Flucklinger V. Assembly defects of multiple respiratory chain complexes in a child with cardiac hypertrophy associated with a novel ACAD9 mutation. Mol. Genet. Metab. 2017;121:224–226. - PubMed
    1. Lagoutte-Renosi J., Ségalas-Milazzo I., Crahes M., Renosi F., Menu-Bouaouiche L., Torre S., Lardennois C., Rio M., Marret S., Brasse-Lagnel C., Laquerrière A., Bekri S. Lethal neonatal progression of fetal cardiomegaly associated to ACAD9 deficiency. JIMD Rep. 2015 Oct;17 - PMC - PubMed
    1. Aintablian H.K., Narayanan V., Belnap N., Ramsey K., Grebe T.A. An atypical presentation of ACAD9 deficiency: diagnosis by whole exome sequencing broadens the phenotypic spectrum and alters treatment approach. Mol. Genet. Metab. 2016;10:38–44. - PMC - PubMed
    1. Dewulf J.P., Barrea C., Vincent M.F., De Laet C., Van Coster R., Seneca S., Marie S., Nassogne M.C. Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: report on nine patients. Mol. Genet. Metab. 2016;118:185–189. - PubMed
    1. Collet M., Assouline Z., Bonnet D., Rio M., Iserin F., Sidi D., Goldenberg A., Lardennois C., Metodiev M.D., Haberberger B., Haack T., Munnich A., Prokisch H., Rötig A. High incidence and variable clinical outcome of cardiac hypertrophy due to ACAD9 mutations in childhood. Eur. J. Hum. Genet. 2016;24:1112–1116. - PMC - PubMed

LinkOut - more resources